Global Liquid Biopsy Diagnostic Tool Market Research Report 2024(Status and Outlook)

Global Liquid Biopsy Diagnostic Tool Market Research Report 2024(Status and Outlook)



Report Overview:

Liquid Biopsy Diagnostic Tool is a medical device or technology that analyzes various biomarkers present in bodily fluids, such as blood, to detect diseases like cancer or other health conditions. It offers a less invasive alternative to traditional tissue biopsies.

The Global Liquid Biopsy Diagnostic Tool Market Size was estimated at USD 1505.16 million in 2023 and is projected to reach USD 4471.97 million by 2029, exhibiting a CAGR of 19.90% during the forecast period.

This report provides a deep insight into the global Liquid Biopsy Diagnostic Tool market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liquid Biopsy Diagnostic Tool Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liquid Biopsy Diagnostic Tool market in any manner.

Global Liquid Biopsy Diagnostic Tool Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biocept

Qiagen

Roche Diagnostics

Bio-Rad Laboratories

Myriad Genetics

Menarini-Silicon Biosystems

Trovagene

Guardant Health

Mdxhealth

Genomic Health

Raindance Technologies

Thermo Fisher Scientific

Illumina

Amoy Diagnostics

Johnson & Johnson

Market Segmentation (by Type)

Instrument

Reagent

Others

Market Segmentation (by Application)

Hospital

Third-party Testing Agency

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Liquid Biopsy Diagnostic Tool Market

Overview of the regional outlook of the Liquid Biopsy Diagnostic Tool Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liquid Biopsy Diagnostic Tool Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Liquid Biopsy Diagnostic Tool
1.2 Key Market Segments
1.2.1 Liquid Biopsy Diagnostic Tool Segment by Type
1.2.2 Liquid Biopsy Diagnostic Tool Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Liquid Biopsy Diagnostic Tool Market Overview
2.1 Global Market Overview
2.1.1 Global Liquid Biopsy Diagnostic Tool Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Liquid Biopsy Diagnostic Tool Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Liquid Biopsy Diagnostic Tool Market Competitive Landscape
3.1 Global Liquid Biopsy Diagnostic Tool Sales by Manufacturers (2019-2024)
3.2 Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Manufacturers (2019-2024)
3.3 Liquid Biopsy Diagnostic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liquid Biopsy Diagnostic Tool Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Liquid Biopsy Diagnostic Tool Sales Sites, Area Served, Product Type
3.6 Liquid Biopsy Diagnostic Tool Market Competitive Situation and Trends
3.6.1 Liquid Biopsy Diagnostic Tool Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liquid Biopsy Diagnostic Tool Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Liquid Biopsy Diagnostic Tool Industry Chain Analysis
4.1 Liquid Biopsy Diagnostic Tool Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Liquid Biopsy Diagnostic Tool Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Liquid Biopsy Diagnostic Tool Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liquid Biopsy Diagnostic Tool Sales Market Share by Type (2019-2024)
6.3 Global Liquid Biopsy Diagnostic Tool Market Size Market Share by Type (2019-2024)
6.4 Global Liquid Biopsy Diagnostic Tool Price by Type (2019-2024)
7 Liquid Biopsy Diagnostic Tool Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liquid Biopsy Diagnostic Tool Market Sales by Application (2019-2024)
7.3 Global Liquid Biopsy Diagnostic Tool Market Size (M USD) by Application (2019-2024)
7.4 Global Liquid Biopsy Diagnostic Tool Sales Growth Rate by Application (2019-2024)
8 Liquid Biopsy Diagnostic Tool Market Segmentation by Region
8.1 Global Liquid Biopsy Diagnostic Tool Sales by Region
8.1.1 Global Liquid Biopsy Diagnostic Tool Sales by Region
8.1.2 Global Liquid Biopsy Diagnostic Tool Sales Market Share by Region
8.2 North America
8.2.1 North America Liquid Biopsy Diagnostic Tool Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liquid Biopsy Diagnostic Tool Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liquid Biopsy Diagnostic Tool Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liquid Biopsy Diagnostic Tool Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liquid Biopsy Diagnostic Tool Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biocept
9.1.1 Biocept Liquid Biopsy Diagnostic Tool Basic Information
9.1.2 Biocept Liquid Biopsy Diagnostic Tool Product Overview
9.1.3 Biocept Liquid Biopsy Diagnostic Tool Product Market Performance
9.1.4 Biocept Business Overview
9.1.5 Biocept Liquid Biopsy Diagnostic Tool SWOT Analysis
9.1.6 Biocept Recent Developments
9.2 Qiagen
9.2.1 Qiagen Liquid Biopsy Diagnostic Tool Basic Information
9.2.2 Qiagen Liquid Biopsy Diagnostic Tool Product Overview
9.2.3 Qiagen Liquid Biopsy Diagnostic Tool Product Market Performance
9.2.4 Qiagen Business Overview
9.2.5 Qiagen Liquid Biopsy Diagnostic Tool SWOT Analysis
9.2.6 Qiagen Recent Developments
9.3 Roche Diagnostics
9.3.1 Roche Diagnostics Liquid Biopsy Diagnostic Tool Basic Information
9.3.2 Roche Diagnostics Liquid Biopsy Diagnostic Tool Product Overview
9.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Product Market Performance
9.3.4 Roche Diagnostics Liquid Biopsy Diagnostic Tool SWOT Analysis
9.3.5 Roche Diagnostics Business Overview
9.3.6 Roche Diagnostics Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Basic Information
9.4.2 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Product Overview
9.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Myriad Genetics
9.5.1 Myriad Genetics Liquid Biopsy Diagnostic Tool Basic Information
9.5.2 Myriad Genetics Liquid Biopsy Diagnostic Tool Product Overview
9.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Product Market Performance
9.5.4 Myriad Genetics Business Overview
9.5.5 Myriad Genetics Recent Developments
9.6 Menarini-Silicon Biosystems
9.6.1 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Basic Information
9.6.2 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Product Overview
9.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Product Market Performance
9.6.4 Menarini-Silicon Biosystems Business Overview
9.6.5 Menarini-Silicon Biosystems Recent Developments
9.7 Trovagene
9.7.1 Trovagene Liquid Biopsy Diagnostic Tool Basic Information
9.7.2 Trovagene Liquid Biopsy Diagnostic Tool Product Overview
9.7.3 Trovagene Liquid Biopsy Diagnostic Tool Product Market Performance
9.7.4 Trovagene Business Overview
9.7.5 Trovagene Recent Developments
9.8 Guardant Health
9.8.1 Guardant Health Liquid Biopsy Diagnostic Tool Basic Information
9.8.2 Guardant Health Liquid Biopsy Diagnostic Tool Product Overview
9.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Product Market Performance
9.8.4 Guardant Health Business Overview
9.8.5 Guardant Health Recent Developments
9.9 Mdxhealth
9.9.1 Mdxhealth Liquid Biopsy Diagnostic Tool Basic Information
9.9.2 Mdxhealth Liquid Biopsy Diagnostic Tool Product Overview
9.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Product Market Performance
9.9.4 Mdxhealth Business Overview
9.9.5 Mdxhealth Recent Developments
9.10 Genomic Health
9.10.1 Genomic Health Liquid Biopsy Diagnostic Tool Basic Information
9.10.2 Genomic Health Liquid Biopsy Diagnostic Tool Product Overview
9.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Product Market Performance
9.10.4 Genomic Health Business Overview
9.10.5 Genomic Health Recent Developments
9.11 Raindance Technologies
9.11.1 Raindance Technologies Liquid Biopsy Diagnostic Tool Basic Information
9.11.2 Raindance Technologies Liquid Biopsy Diagnostic Tool Product Overview
9.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Product Market Performance
9.11.4 Raindance Technologies Business Overview
9.11.5 Raindance Technologies Recent Developments
9.12 Thermo Fisher Scientific
9.12.1 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Basic Information
9.12.2 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Product Overview
9.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Product Market Performance
9.12.4 Thermo Fisher Scientific Business Overview
9.12.5 Thermo Fisher Scientific Recent Developments
9.13 Illumina
9.13.1 Illumina Liquid Biopsy Diagnostic Tool Basic Information
9.13.2 Illumina Liquid Biopsy Diagnostic Tool Product Overview
9.13.3 Illumina Liquid Biopsy Diagnostic Tool Product Market Performance
9.13.4 Illumina Business Overview
9.13.5 Illumina Recent Developments
9.14 Amoy Diagnostics
9.14.1 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Basic Information
9.14.2 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Product Overview
9.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Product Market Performance
9.14.4 Amoy Diagnostics Business Overview
9.14.5 Amoy Diagnostics Recent Developments
9.15 Johnson and Johnson
9.15.1 Johnson and Johnson Liquid Biopsy Diagnostic Tool Basic Information
9.15.2 Johnson and Johnson Liquid Biopsy Diagnostic Tool Product Overview
9.15.3 Johnson and Johnson Liquid Biopsy Diagnostic Tool Product Market Performance
9.15.4 Johnson and Johnson Business Overview
9.15.5 Johnson and Johnson Recent Developments
10 Liquid Biopsy Diagnostic Tool Market Forecast by Region
10.1 Global Liquid Biopsy Diagnostic Tool Market Size Forecast
10.2 Global Liquid Biopsy Diagnostic Tool Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liquid Biopsy Diagnostic Tool Market Size Forecast by Country
10.2.3 Asia Pacific Liquid Biopsy Diagnostic Tool Market Size Forecast by Region
10.2.4 South America Liquid Biopsy Diagnostic Tool Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liquid Biopsy Diagnostic Tool by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Liquid Biopsy Diagnostic Tool Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Liquid Biopsy Diagnostic Tool by Type (2025-2030)
11.1.2 Global Liquid Biopsy Diagnostic Tool Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Liquid Biopsy Diagnostic Tool by Type (2025-2030)
11.2 Global Liquid Biopsy Diagnostic Tool Market Forecast by Application (2025-2030)
11.2.1 Global Liquid Biopsy Diagnostic Tool Sales (K Units) Forecast by Application
11.2.2 Global Liquid Biopsy Diagnostic Tool Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings